WuXi Advanced Therapies

Have you signed up for the San Francisco Advanced Therapies Xchange sponsored by hubXchange taking place on September 25th??If not, sign-up here https://lnkd.in/eVkm7WuU Simona Jusyte, Peter Colbourne and Stephen Wang will all be in attendance. Simona Jusyte will kick-things off with her presentation entitled?“Setting the Stage for Successful QC Testing & Lot Release”.?If you are in the area and can meet the team while they are in San Francisco contact us to get something on the calendar! https://lnkd.in/enScFd3C

Corinne Branciaroli and Keith Meaney from our OXGENE team attended Phacilitate Advanced Therapies Europe this week in Lisbon, Portugal as part of the BioIndustry Association (BIA) pavilion. If you didn’t have the opportunity to meet with them while you were there, message us and we’ll put you in touch with them!?If you were among the close to 600 attendees and 40 countries represented during the week we hope you enjoyed the networking, presentations, and discussions as much as they did!?

If you're attending the CAR-TCR Summit Series in Boston the week of the 16th, don't miss Heather Malicki, Ph.D.’s presentation “Streamline Product Release to Improve Vein-to-Vein Time” on Wednesday at 11:10am EST. Simona Jusyte and JJ Sheehan will also be at the event. Stop by our booth, schedule a meeting via the event portal, or submit a meeting request here https://lnkd.in/eb4GTP7D #CARTCR #CGT #CellandGeneTherapy

We are proud and honored to be a sponsor of this year's Believe Ball and look forward to an evening of inspiration and an opportunity to demonstrate our support of the Emily Whitehead Foundation!

? We are pleased to announce that our XOFLX? stable packaging and producer cell lines technology has been reviewed and the corresponding manuscript is now published by Molecular Therapy – Methods & Clinical Development, which is part of the Molecular Therapy family, the official journals of the American Society of Gene & Cell Therapy. The article, entitled “Lentiviral Vector Packaging and Producer Cell Lines Yield Titres Equivalent to the Industry-Standard Four-Plasmid Process” was recently published online and can be accessed here https://lnkd.in/dzHEdj6G. Congratulations to all our authors, many of which are from OXGENE, a WuXi Advanced Therapies company, dedicated to providing the industry with forward-thinking and innovative technologies and services that accelerate the discovery and development of cell and gene therapies. ? XOFLX? stable technology and corresponding packaging and producer cell lines offer a simplified high-yielding LVV manufacturing system that lowers costs & improves process consistency. To learn more please message us or visit https://lnkd.in/eHBXc-dy ? #LVV, #XOFLX, #OXGENE

? WuXi Advanced Therapies is a strong supporter of the Emily Whitehead Foundation and their mission to raise awareness and help fund advanced therapeutics like the one that saved Emily’s life.?? ? As many of you know, Emily was the first pediatric patient enrolled in what was then a highly experimental phase I clinical trial called CAR-T cell therapy at Children's Hospital of Philadelphia and became the first child in the world to have her immune system trained to fight cancer. The experimental T-cell therapy worked and Emily is now approaching ten years cancer free. ? We are initiating a book club at WuXi Advanced Therapies and more than 70 of our employees have signed up to receive a copy of Emily’s story which was co-authored by Emily and her parents. The book, titled Praying for Emily: The Faith, Science, and Miracles that Saved Our Daughter?is a heart wrenching and compelling account of her journey.? ? What’s especially exciting is Tom Whitehead will visit our site at the Navy Yard in Philadelphia on Friday September 13th and join our inaugural book club meeting to discuss the book he authored and answer readers questions.?We can’t wait and will post pictures of his visit too!? ? #EmilyWhiteheadFoundation, #cartcelltherapy, #patientadvocacy, #cellandgenetherapy, #activatethecure ?

Join us at #ATE24 -- the gateway to Europe’s dynamic biotech landscape! Phacilitate's Advanced Therapies Europe is looking to be a well-attended event with a packed agenda of panel discussions, presentations, and roundtables. You can find members of our team in the BioIndustry Association (BIA)'s pavilion which is stand #53.?Look for Keith Meaney and Corinne Branciaroli. Both will be on site and willing to meet. Message us to arrange a time or submit a request online at https://lnkd.in/d4fyRPZV.

Meet Kathleen (Kenney) McGrogan!?Kathleen has been with WuXi Advanced Therapies for 13 years and has been the Director of Viral Clearance since December 2022.?She earned her degree from the University of Pittsburgh and has the pleasure of leading a highly motivated team which focuses on continuous process improvement initiatives to maintain high quality and achieve efficient workflow.

On Saturday, a team of 37 employees, friends, and family participated in the 2024 Miles For Melanoma 5K in support of the Melanoma Research Foundation.?Melanoma is the deadliest and fastest growing form of skin cancer, and we all want a cure to be found soon. #MilesforMelanoma is one of the ways people come together to support the Melanoma Research Foundation. The team raised more than $2,500 to support the organization’s mission to eradicate melanoma by accelerating medical RESEARCH while EDUCATING to and ADVOCATING for the melanoma community. ? Manufacturing operators, QC analysts, scientists, managers, engineers, lab technicians, and other team members joined the festivities at the Philadelphia Zoo which in addition to WuXi Advanced Therapies, included multiple teams formed to rally around survivors, current patients, and the family and friends of warriors who have lost their lives to Melanoma.?Sponsors included industry leaders like Pfizer, Merck and BMS as well as health care providers like Jefferson Health and the Fox Chase Center and biotech companies like Castle Biosciences and Iovance Biotherapeutics. ? Congratulations to all our participants and especially Stephen Frasco who came in 5th overall and Benjamin Weber who finished 7th as well as Alyssa Fisher, MS and Sara Benson, M.S. who finished 2nd in their age groups and in the top 10 of all females. ? We appreciate all our runners and walkers for getting up early on a Saturday morning and helping with fundraising and we especially thank all of those who donated to the #MRF to help support the fight against Melanoma! We are humbled and honored to work in this industry and dedicated to all the patients we serve. ? #MRF #MilesforMelanoma #MFMPhiladelphia ?

Meet Melissa McDonnell who will be celebrating her 13th anniversary with WuXi Advanced Therapies on October 31st of this year. Melissa is the Product Director for our Testing organization and a Penn State University graduate! As product director, Melissa focuses on the fact that with both in-house manufacturing AND testing capabilities WuXi Advanced Therapies has the expertise and capacity to help our clients transition their products from early phase concepts to commercially approved treatments. ? Melissa is also very active in the industry and involved in our local Women In Bio - Engage. Educate. Empower. chapter. She’s a passionate supporter of activities focused on mentoring and educating young people about the opportunities in our field.